Both in Medical Labs
Sera Prognostics vs Lumexa Imaging Holdings
Over the past year SERA returned −40.3% and LMRI returned −37.3%; their daily moves had a correlation of 0.05.
SERA −40.3% LMRI −37.3%Growth of $1, one year, split-adjusted
| Metric | SERA | LMRI |
|---|---|---|
| Price | $2.03 | $11.62 |
| Market cap | $80.1M | $1.12B |
| Today | −0.98% | −0.43% |
| 1 month | +1.0% | +13.3% |
| 6 months | +2.0% | +24.0% |
| Year to date | −31.2% | −37.2% |
| 1 year | −45.7% | — |
| Revenue growth (YoY) | +76.5% | — |
| Gross margin | −66.7% | 14.7% |
| Net margin | −30463.3% | 1.0% |
| P/E (TTM) | — | — |
| Price / sales | 1,144.0× | — |
| Net cash | $46.4M | -$820.2M |
| Dividend yield | — | — |
| Volatility (60d) | 34.0% | 37.0% |
| Short % of float | 0.7% | 7.4% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).